Skip to main content

Santarus, Inc. (NASDAQ:SNTS) Investor Investigation Over Potential Wrongdoing In Acquisition

  • If you purchased shares of Santarus, Inc. (NASDAQ:SNTS) and currently hold any of those NASDAQ:SNTS shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

November 11, 2013 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Santarus, Inc. (NASDAQ:SNTS) shares, was announced concerning whether the takeover of Santarus, Inc. by Salix Pharmaceuticals, Ltd for $32.00 per share is unfair to NASDAQ:SNTS stockholders. The investigation by a law firm concerns whether certain officers and directors ...

You must register (for free) or login to view the entire investigation.